Peritoneal Cancer (Cytoreductive Surgery)

Cancer Treatments

Quick Enquiry

Comprehensive Peritoneal Cancer Treatment with Cytoreductive Surgery in Indore

Facing a diagnosis of peritoneal cancer can be overwhelming. At Global Cancer Hub in Indore, we offer advanced treatment options, including cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC), to provide our patients with the best possible outcomes. Our multidisciplinary team is dedicated to delivering personalized care tailored to each patient’s unique needs.

Understanding Peritoneal Cancer and Cytoreductive Surgery

Peritoneal cancer affects the peritoneum, the lining of the abdominal cavity. It can be primary or more commonly secondary, spreading from other abdominal organs such as the colon, stomach, or ovaries. Cytoreductive surgery aims to remove visible tumors from the peritoneal surface, reducing tumor burden and enhancing the effectiveness of subsequent treatments like HIPEC.

Why Choose Global Cancer Hub for Peritoneal Cancer Treatment?

Expert Surgical Team: Led by Dr. Ashwin Rangole, our team has extensive experience in performing complex cytoreductive surgeries.
Advanced Facilities: State-of-the-art operating rooms equipped for HIPEC procedures.
Advanced Techniques: Utilization of the latest surgical methods for optimal outcomes.
Comprehensive Support: Multidisciplinary team providing holistic care, including counseling and rehabilitation services.

Signs & Symptoms of Peritoneal Cancer

Abdominal pain or discomfort
Bloating or a feeling of fullness
Unexplained weight loss
Nausea or changes in bowel habits
Fatigue

Fatigue
Diagnosis & Evaluation

Accurate diagnosis is crucial for effective treatment planning. Our diagnostic approach includes:

Imaging Studies: CT scans, MRI, and PET scans to assess the extent of disease spread.
Diagnostic Laparoscopy: A minimally invasive procedure to visualize the peritoneal cavity and obtain tissue samples.
Tumor Markers: Blood tests to detect specific markers associated with peritoneal cancer

Treatment Approach

Our treatment strategy for peritoneal cancer involves:

Cytoreductive Surgery (CRS): Surgical removal of visible tumors within the peritoneal cavity.
Hyperthermic Intraperitoneal Chemotherapy (HIPEC): After CRS, heated chemotherapy is circulated within the abdomen to eliminate microscopic cancer cells.

This combined approach has shown improved survival rates and quality of life for selected patients.

Advanced
Surgical Techniques

At Global Cancer Hub, we employ advanced surgical techniques to enhance treatment efficacy:

Minimally Invasive Surgery: Where appropriate, laparoscopic methods are used to reduce recovery time.
Organ Preservation: Efforts are made to preserve organ function while ensuring complete tumor removal.
Multidisciplinary Collaboration: Our surgical team works closely with medical oncologists, radiologists, and pathologists for comprehensive care.

Recovery, Follow-up & Support

Postoperative care is integral to patient recovery:

Intensive Monitoring: Patients are closely monitored in the immediate postoperative period.
Rehabilitation Services: Physical therapy and nutritional support to aid recovery.
Regular Follow-ups: Scheduled visits to monitor for recurrence and manage any long-term effects.

FAQs

What is the success rate of cytoreductive surgery with HIPEC?
Success rates vary depending on cancer type and stage, but studies have shown improved survival rates in selected patients undergoing CRS with HIPEC.

Who is a candidate for cytoreductive surgery?
Patients with peritoneal carcinomatosis from certain cancers, without distant metastases, and in good overall health may be considered candidates.

How long is the hospital stay after the procedure?
Hospital stays can range from 7 to 14 days, depending on the surgery’s extent and the patient’s recovery.

Are there risks associated with CRS and HIPEC?
As with any major surgery, there are risks, including infection, bleeding, and organ dysfunction. Our team takes all precautions to minimize these risks.